Recent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data
A recent report published by the American Association for Cancer Research titled Subgroup Analyses in Oncology Trials: Regulatory…
Rapid Dose Therapeutics Announces Formation & Appointment of Advisory Board
Rapid Dose Therapeutics (CSE:DOSE) is a biotechnology company revolutionizing drug delivery through innovation, specifically with their flagship product…
Presenters Announced for 2021 William Blair Biotech Conference
A wide range of biotechnology companies have announced presentations at the upcoming William Blair Biotech Conference slated to…
William Blair Biotech Focus Conference 2021 Panel Schedule
Day One 2021 William Blair Biotech Conference July 14th Panels Panel Name: Cell Therapies in the Next Decade…
BioLab Sciences Appoints New VP of Sales Mark Denning
Emerging regenerative biotechnology company BioLab Sciences announced today that it has appointed industry veteran Mark Denning as VP…
BioTech Health X CEO Series: Virios Therapeutics Greg Duncan
BioTech Health X works to deliver the latest coverage and updates in the biotechnology sector. This includes providing…
Allay Therapeutics Appoints New Chief Medical Officer
David Hewitt, M.D. Appointed as New Allay Therapeutics Chief Medical Officer Clinical-stage biotechnology company Allay Therapeutics recently announced…